Mycenax (4726.TWO) monthly revenue, September 2026

Name: Mycenax (4726) monthly revenue 2026-09 | Value Ledger
Creator: Value Ledger
License: https://creativecommons.org/licenses/by/4.0/

Mycenax reported revenue of NT$116.4 million for September 2026, up 9.9% from the previous month and up 393.3% from a year earlier. Year-to-date revenue was NT$708.1 million, up 55.4% year on year. It ranked 3 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.

中文版

Month	Revenue NT$bn	MoM %	YoY %
September 2026	0.12	9.9	393.3